Journal List > Korean J Gastroenterol > v.73(1) > 1112135

Kwon, Cho, Lee, Kwon, and Lee: Immunoglobulin G4 Unrelated Idiopathic Mesenteric Sclerosis

Abstract

Sclerosing mesenteritis is a rare benign disease with a prevalence of 0.16–3.4% and is characterized by chronic nonspecific inflammation and extensive fibrosis in the adipose tissue of the mesentery although the exact pathogenesis is still elusive. A 65-year-old woman was referred with suspicion of an abdominal mass and biliary stones on abdominal ultrasonography and CT. Bile duct stones were confirmed by endoscopic ultrasonography and successfully treated by endoscopic retrograde cholangiography with stone removal. Furthermore, a 4.7 cm conglomerated mass on small intestinal mesentery was suspected as sclerosing mesenteritis based on the features on abdominal MRI. However, because it could not be differentiated from malignancy without histologic examination, laparoscopic excisional biopsy was performed; it showed only inflammatory cells with extensive fibrosis. Therefore, the abdominal mass was confirmed as sclerosing fibrosis and the patient was followed-up without any treatments because no mass-related symptoms accompanied the findings. Six months later, abdominal CT showed no significant change in the mass. Herein, we report a rare case of incidentally found idiopathic sclerosing mesenteritis.

References

1. Badet N, Sailley N, Briquez C, Paquette B, Vuitton L, Delabrousse É. Mesenteric panniculitis: still an ambiguous condition. Diagn Interv Imaging. 2015; 96:251–257.
crossref
2. Min BH, Shinn YC. Idiopathic mesenteric fibrosis. J Korean Surg Soc. 1976; 18:73–76.
3. Chung W, Park KC. A case report of sclerosing mesenteritis. Eulji J Med. 1982; 5:85–86.
4. Cha SJ, Lim HM, Chang ST, Park YW, Yoo JH, Song KY. Primary mesenteritis: a case report. J Korean Surg Soc. 1991; 41:819–829.
5. Jung TY, Lee CW. A case report of the mesenteric panniculitis. J Korean Surg Soc. 1992; 43:916–919.
6. Park KH, Chang HK, Choi SY, et al. Sclerosing mesenteritis associated with skin panniculitis and pleural thickening. Korean J Med. 1999; 57:103–107.
7. Park SD, Bae OS. Cases of postoperative mesenteric panniculitis. J Korean Soc Coloproctol. 2002; 18:128–132.
8. Lee SY, Park DE, Chae KM. Sclerosing mesenteritis. J Korean Surg Soc. 2006; 71:218–221.
9. Li LY, Cho YK, Lee JH, et al. Two cases of mesenteric panniculitis treated by medical management. Korean J Med. 2006; 71:S934–S939.
10. Kim EG, Kang YW, Yoon SG, Kim HD, Kim KY. Four cases of post-operative sclerosing mesenteritis. J Korean Soc Coloproctol. 2007; 23:374–380.
crossref
11. Jung SH, Paik CN, Jung JH, Lee KM, Chung WC, Yang JM. Simultaneous colonic obstruction and hydroureteronephrosis due to mesenteric fibromatosis. Gut Liver. 2009; 3:215–217.
crossref
12. Bae JH, Kim SH, Ahn SB, et al. A case of idiopathic sclerosing mesenteritis with retroperitoneal fibrosis. Korean J Gastroenterol. 2011; 58:221–225.
crossref
13. Lee HJ, Kim JI, Ahn JW, et al. Spontaneous regression of sclerosing mesenteritis presenting as a huge mass. Korean J Gastroenterol. 2012; 59:317–320.
crossref
14. Kim EJ, Kim EY, Song JE, et al. A case of IgG4-related sclerosing mesenteritis associated with Crohn's disease. Korean J Gastroenterol. 2014; 63:176–182.
crossref
15. Lee SJ, Park CK, Yang WI, Kim SK. IgG4-related sclerosing mesenteritis. J Pathol Transl Med. 2016; 50:309–311.
crossref
16. Avincsal MO, Otani K, Kanzawa M, et al. Sclerosing mesenteritis: a real manifestation or histological mimic of IgG4-related disease? Pathol Int. 2016; 66:158–163.
crossref
17. Emory TS, Monihan JM, Carr NJ, Sobin LH. Sclerosing mesenteritis, mesenteric panniculitis and mesenteric lipodystrophy: a single entity? Am J Surg Pathol. 1997; 21:392–398.
crossref
18. Chen TS, Montgomery EA. Are tumefactive lesions classified as sclerosing mesenteritis a subset of IgG4-related sclerosing disorders? J Clin Pathol. 2008; 61:1093–1097.
crossref
19. Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012; 25:1181–1192.
20. Sharma P, Yadav S, Needham CM, Feuerstadt P. Sclerosing mesenteritis: a systematic review of 192 cases. Clin J Gastroenterol. 2017; 10:103–111.
crossref

Fig. 1.
Initial abdominal CT (A) and MRI (B) images show a 4.7 cm conglomerated mesenteric mass with enhancement at periumbilical area (arrows). CT, computed tomography; MRI, magnetic resonance imaging.
kjg-73-50f1.tif
Fig. 2.
Gross finding of laparoscopic excisional biopsy of the mesenteric mass. The submitted specimen was a piece of irregular fibroadipose tissue measuring 1.2×0.9×0.5 cm in size.
kjg-73-50f2.tif
Fig. 3.
Histopathologic findings of sclerosing mesenteritis. (A) Diffuse fibrosclerosis with infiltrate of inflammatory cells and dystrophic calcification (H&E, ×40). (B) A moderate infiltrate of chronic inflammatory cells with collagen deposition (H&E, ×200). (C) The inflammatory infiltrate was abundant plasma cells and lymphocytes in marked fibrosclerosis (left upper corner) (H&E, ×400). (D) Obliterative phlebitis: in high power view of histologic findings, there are foci of a heavy infiltrate of perivenular and intravascular inflammatory cells with obliteration of vascular lumen (H&E, ×400).
kjg-73-50f3.tif
Fig. 4.
Immunohistochemical staining shows markedly increased IgG-positive plasma cells (A, ×400) and complete IgG4 negativity (B,×400). Ig, immunoglobulin.
kjg-73-50f4.tif
Fig. 5.
Abdominal computed tomography of axial (A) and coronal (B) images after six months of follow-up show no specific change in size or nature of the mass lesion (arrows).
kjg-73-50f5.tif
Table 1.
Reported Cases of Sclerosing Mesenteritis in Korea
Case Study Age/sex Symptom Operation Tissue lgG4 Treatment Follow up Response to treatment
1 Min and Shinn (1976)2 33/F Abdominal pain Unrelated N/A Surgical resection 4 days Symptom Improved
2 Chung and Park (1982)3 30/F Abdominal pain, nausea Relation not specified N/A Steroid 13 days Symptom not improved
3 Cha et al. (1991)4 62/F Abdominal pain, palpated mass Unrelated N/A Surgical resection 2 months Symptom Improved
4 Jung and Lee (1992)5 38/M Palpated mass Abdominal mass excision N/A Surgical resection 42 days Symptom Improved
5 Park et al. (1999)6 53/F Abdominal pain, nausea, vomiting Unrelated N/A Surgical resection+medical treatment (prednisolone+cyclophosphamide) Not specified Symptom Improved
6 Park and Bae (2002)7 57/M Abdominal discomfort, nausea, vomiting Right hemicolectomy N/A Surgical resection 1 year Symptom Improved
7 Park and Bae (2002)7 68/M Abdominal discomfort, nausea, vomiting Lower anterior resection N/A Surgical dissection 18 days Symptom improved
8 Park and Bae (2002)7 59/F Not specified Left hemicolectomy N/A Surgical dissection+medical treatment (steroid +colchicine) 16 days Symptom improved
9 Lee et al. (2006)8 59/M Abdominal pain, nausea, vomiting Unrelated N/A Surgical resection 3 days Symptom Improved
10 Li et al. (2006)9 73/M Abdominal pain Appendectomy N/A Conservative treatment 30 days Partial regression
11 Li et al. (2006)9 66/F Abdominal pain Unrelated N/A Antibiotics 2 months Partial regression
12 Kim et al. (2007)10 58/M Abdominal pain, nausea, vomiting Right hemicolectomy N/A Surgical resection 27 days Symptom Improved
13 Kim et al. (2007)10 50/M Abdominal pain, nausea, vomiting Small bowel resection N/A Surgical resection 13 days Symptom Improved
14 Kim et al. (2007)10 60/F Abdominal pain, nausea, vomiting lleosigmoidostomy N/A Surgical anastomosis 10 months Symptom Improved
15 Kim et al. (2007)10 72/M Abdominal discomfort, vomiting Small bowel resection N/A Surgical resection 11 months Symptom Improved
16 Jung et al. (2009)11 49/F Abdominal pain, constipation Hysterectomy N/A Conservative treatment Not specified Symptom Improved
17 Bae et al. (2011)12 58/M Abdominal pain Unrelated N/A Medical treatment (prednlsolone+cyclophosphamide) 5 months Symptom Improved
18 Lee et al. (2012)13 54/M Palpated mass Unrelated N/A None 3 months Partial regression
19 Kim et al. (2014)14 45/F Palpated mass Unrelated positive Surgical resectlon+medical treatment (prednisolone+azathioprine) 13 months Symptom Improved
20 Lee et al. (2016)15 70/F Palpated mass Unrelated positive Surgical resectlon+medical treatment (steroid) Not specified Not specified
21 This study (2018) 65/F RUQ pain Unrelated negative None 6 months No regression or progression

F, female; N/A, not applicable; M, male; RUQ, right upper quadrant.

TOOLS
ORCID iDs

Kwang Bum Cho
https://orcid.org/0000-0003-2203-102X

Similar articles